Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as grindeks, krustpils iela 53, riga, latvija - lenalidomid amonijev klorid - kapsula, tvrda - 10 mg - urbroj: jedna kapsula sadrži 10 mg lenalidomida (u obliku lenalidomid amonijevog klorida)

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as grindeks, krustpils iela 53, riga, latvija - lenalidomid amonijev klorid - kapsula, tvrda - 15 mg - urbroj: jedna kapsula sadrži 15 mg lenalidomida (u obliku lenalidomid amonijevog klorida)

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as grindeks, krustpils iela 53, riga, latvija - lenalidomid amonijev klorid - kapsula, tvrda - 20 mg - urbroj: jedna kapsula sadrži 20 mg lenalidomida (u obliku lenalidomid amonijevog klorida)

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as grindeks, krustpils iela 53, riga, latvija - lenalidomid amonijev klorid - kapsula, tvrda - 25 mg - urbroj: jedna kapsula sadrži 25 mg lenalidomida (u obliku lenalidomid amonijevog klorida)

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as grindeks, krustpils iela 53, riga, latvija - lenalidomid amonijev klorid - kapsula, tvrda - 5 mg - urbroj: jedna kapsula sadrži 5 mg lenalidomida (u obliku lenalidomid amonijevog klorida)

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as grindeks, krustpils iela 53, riga, latvija - lenalidomid amonijev klorid - kapsula, tvrda - 7,5 mg - urbroj: jedna kapsula sadrži 7,5 mg lenalidomida (u obliku lenalidomid amonijevog klorida)

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as grindeks, krustpils iela 53, riga, latvija - lenalidomid amonijev klorid - kapsula, tvrda - 2,5 mg - urbroj: jedna kapsula sadrži 2,5 mg lenalidomida (u obliku amonijevog klorida)

Europska Unija - hrvatski - EMA (European Medicines Agency)

accord healthcare s.l.u. - lenalidomid - multipli mijelom - imunosupresivi - multiple myelomalenalidomide accord as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide accord as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. akord леналидомид u kombinaciji s дексаметазоном indiciran za liječenje multiple myeloma kod odraslih pacijenata koji su primili barem jedan tečaj terapija. follicular lymphomalenalidomide accord in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Europska Unija - hrvatski - EMA (European Medicines Agency)

mylan ireland limited - lenalidomid - multipli mijelom - imunosupresivi - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).

Europska Unija - hrvatski - EMA (European Medicines Agency)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - imunosupresivi - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).